Searched for
EYESTEM FUNDING
After deeptech firms, expect RDIF rollout for Indian VCs soonLast month, close to 20 Indian investors, which included Ideaspring Capital, Speciale Invest, Chiratae Ventures, Sixth Sense Ventures, and ...
Industry sees Budget 2026–27 as execution-oriented, capital-friendly, and future-readyLeaders across private equity, infrastructure, technology, real estate, telecom, and healthcare welcome the Budget’s focus on execution, ca...
Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPEEyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment ...
Endiya Partners leads AltiusHub’s $2.25 million fundraiseFounded in 2023, AltiusHub is a supply chain visibility software designed to help manufacturing companies safeguard their supply chains. In...
Endiya Partners announces third fund with corpus of up to $125 millionThe early-stage firm will start deploying the fund in a quarter or 3-4 four months from now. The fund will focus on deeptech, health, softw...
Budget: Enabling sustainable and investment-led economic growthAchieving high resilient growth while ensuring sustainable and inclusive livelihood options for all remains a priority for India. The inter...
Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye InstituteLimitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.
ET Startup Awards 2022: India may ride out global stormStartup founders, CEOs and policymakers stress on the need to reassess biz plans, valuation expectations amid funding woes. Companies with ...
Facebook’s Meta-morphosis & this week's top tech storiesAround this time last year, Facebook – the world’s biggest social media company – decided to change course and rename itself Meta. Twelve m...
ET's star and stirring 2022 startup line-upThe awards were tightly contested, demonstrating a pipeline of innovation and enterprise that is steadily improving the economy's productiv...
ETSA 2022: And the winners are…This year’s meeting took place against the backdrop of widespread turmoil across public and private markets, which has slashed the valuatio...
ET Startup Awards 2022: Eyestem bags the Top Innovator awardEyestem’s aim to treat “incurable” eye diseases helped it pip Haber, an artificial intelligence powered startup that simplifies manufacturi...
ET Startup Awards 2022: All the detailsThe winners of the 2022 edition of the Economic Times Startup Awards, which recognise and celebrate excellence in the Indian startup ecosys...
Why are investors shying away from biotech startups?Investors have largely been risk-averse when it comes to deep-funding biotech startups that have the potential to turn into billion-dollar ...
Incubated at C-CAMP, seven deeptech startups have raised more than Rs 550 croreC-CAMP is one of the largest biotech ecosystems in India and a global hub for innovations led by deep-tech.
ETtech Deals Digest: UpGrad closes one of the biggest deals of the yearupGrad and Clevertap raised a combined $315 million this week.
Eyestem raises Series A round from Biological E, Alkem and othersThe investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.
Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & NatcoExisting investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Cror...
Eyestem has a visionary approach to make cell therapy affordable in IndiaCell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...
India all set for the biotech bounce among its startupsA new set of deep science startups is delving into subjects as diverse as medicine, energy and agri to lay the foundation for a large biote...